Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of NMRC-M3V-Ad-PfCA Malaria Vaccine in Healthy Adults
NCT00392015Phase 2Completed
- Sponsor
- U.S. Army Medical Research and Development Command
- Start
- Oct 2006
- Primary completion
- Jun 2016
- Modality
- Prophylactic Vaccines, Viral Vectors, DNA Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of NMRC-M3V-Ad-PfCA in malaria, sponsored by U.S. Army Medical Research and Development Command. Started Oct 2006; status: completed.
02
Drugs
NMRC-M3V-Ad-PfCA
03
Conditions
malaria
Beyond the preview
Go deeper on NCT00392015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00392015.